237 related articles for article (PubMed ID: 11151748)
1. Ranitidine clearance during hemodialysis with high-flux membrane: comparison of polysulfone and cellulose acetate hemodialyzers.
Tsuruoka S; Sugimoto KI; Hayasaka T; Saito T; Fujimura A
Eur J Clin Pharmacol; 2000 Nov; 56(8):581-3. PubMed ID: 11151748
[TBL] [Abstract][Full Text] [Related]
2. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
5. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
[TBL] [Abstract][Full Text] [Related]
6. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
7. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
[TBL] [Abstract][Full Text] [Related]
9. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers.
Sowinski KM; Mueller BA; Grabe DW; Manley HJ; Frye RF; Bailie GR; Marx MA
Am J Kidney Dis; 2001 Apr; 37(4):766-76. PubMed ID: 11273877
[TBL] [Abstract][Full Text] [Related]
10. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers.
Albright RC; Smelser JM; McCarthy JT; Homburger HA; Bergstralh EJ; Larson TS
Mayo Clin Proc; 2000 Nov; 75(11):1141-7. PubMed ID: 11075743
[TBL] [Abstract][Full Text] [Related]
11. [Effects of hemodialysis membrane on serum lipid profile of maintenance hemodialysis patients].
Tanaka H; Nishikawa O; Yukawa S; Yoshimoto M; Nishide I
Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):1-7. PubMed ID: 10077981
[TBL] [Abstract][Full Text] [Related]
12. Reduced iopromide elimination in hemodialysis with cuprophan membranes.
Matzkies FK; Reinecke H; Tombach B; Koeneke J; Hohage H; Kisters K; Schaefer RM
Acta Radiol; 2000 Nov; 41(6):671-3. PubMed ID: 11092496
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes.
DeSoi CA; Sahm DF; Umans JG
Am J Kidney Dis; 1992 Oct; 20(4):354-60. PubMed ID: 1415203
[TBL] [Abstract][Full Text] [Related]
15. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
16. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis.
Abe M; Okada K; Ikeda K; Matsumoto S; Soma M; Matsumoto K
Artif Organs; 2011 Apr; 35(4):398-403. PubMed ID: 21314833
[TBL] [Abstract][Full Text] [Related]
17. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material?
Hoffmann U; Fischereder M; Marx M; Schweda F; Lang B; Straub RH; Krämer BK
Am J Nephrol; 2003; 23(6):442-7. PubMed ID: 14583663
[TBL] [Abstract][Full Text] [Related]
19. Effect of hemodialysis membrane type on parathyroid hormone removal.
Kudlac H; Fielding AM; Williams AJ
Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
[TBL] [Abstract][Full Text] [Related]
20. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
